Journal of Gastrointestinal Infections

Register      Login

VOLUME 6 , ISSUE 1 ( 2016 ) > List of Articles

EDITORIAL

Hepatitis B virus-related liver diseases: Identity and evidence-based control strategy

Citation Information : Hepatitis B virus-related liver diseases: Identity and evidence-based control strategy. J Gastrointest Infect 2016; 6 (1):1-2.

DOI: 10.5005/jp-jogi-6-1-1

License: CC BY-SA 4.0

Published Online: 01-12-2016

Copyright Statement:  Copyright © 2016; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Seeger C, Mason WS. Molecular biology of hepatitis B virus infection. Virology. 2015;479-80:672-86.
  2. Hadziyannis SJ, Vassilopoulos D, Hadziyannis E. The natural course of chronic hepatitis B virus infection and its management. Adv. Pharmacol 2013;67:247-91.
  3. Maini MK, Boni C, Lee CK, Larrubia JR, Reignat S, Ogg GS, et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J. Exp. Med. 2000;191:1269-80.
  4. Sprengers D, Janssen HL. Immunomodulatory therapy for chronic hepatitis B virus infection. Fund. Clin. Pharmacol. 2005; 19:17-26.
  5. Akbar SM, Al-Mahtab M, Khan MS. Non-antigen-specific and antigen-specific immune therapies for chronic hepatitis B: evidences from laboratory benches and patient's bedsides. Expert Opin Biol Ther. 2013;13:1063-74.
  6. Akbar SM, Al-Mahtab M, Jahan M, Yoshida O, Hiasa Y. Novel insights into immunotherapy for hepatitis B patients. Expert Rev Gastroenterol Hepatol. 2016;10:267-76.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.